Insight
Insight is a medical research platform that helps scientists move from a research question to literature-backed summaries, hypotheses, and structured experiment plans. You define a medical research objective, and the platform runs tasks against peer-reviewed biomedical databases to build cited outputs. It is free to try, with optional registration to save objectives on a personal dashboard.
The workflow centers on iterative research cycles. After you submit an objective, Insight outlines a plan in its Thoughts output, then executes tasks against integrated sources including PubMed, NIH RePORTER, ClinicalTrials.gov, MyGene, and MyVariant. Each completed cycle refines the plan and deepens the scientific summary, hypotheses, and citations tied to your question.
Insight Research is available now for literature review, hypothesis generation, and experimental design drafting. Insight Discovery, a separate high-throughput module for target and biomarker identification, remains waitlist-only. The platform is built for researchers in drug discovery, clinical research, and genetics who want structured assistance without manually searching across separate NIH and genomic databases.
Founded in August 2023, Insight positions itself as an accessible research studio for medical scientists. The team publishes documentation, offers email and Discord support, and integrates data sources spanning more than 36 million PubMed articles, 22 million genes, and 400 million human variants.
Searches 36+ million PubMed articles for one-click scientific summaries
Runs tasks against NIH RePORTER, ClinicalTrials.gov, MyGene, and MyVariant
Turns a specific research objective into testable hypotheses automatically
Generates experimental designs with timelines, budgets, and procedures
Exports experimental designs as PDF reports with cited references
Pulls from peer-reviewed sources including PubMed, NIH RePORTER, and ClinicalTrials.gov
Free to try with optional account registration to save research objectives
Generates experimental designs with timelines, budgets, and cited references
MyGene covers 22M+ genes; MyVariant integrates 400M+ human variants
Objective-based workflow with iterative cycles that refine outputs over time
Insight Discovery high-throughput features require joining a waitlist
No dedicated pricing page; commercial plan details are not published on the site
Documentation lives on a separate docs subdomain from the main app
No mobile app; the platform is web-based only
Is Insight free to use?
Yes. Insight invites users to try the platform for free from its homepage. You can browse without logging in, and registering an account lets you save previous objectives and maintain a personalized dashboard.
What databases does Insight connect to?
Insight integrates NIH PubMed, NIH RePORTER, NIH ClinicalTrials.gov, MyGene, and MyVariant. These sources cover peer-reviewed literature, active grants, clinical trials, gene data across 22,000+ species, and more than 400 million human variants.
Do I need an account to use Insight?
No. Insight does not require login for browsing. To save prior objectives and access a personalized dashboard, you can register for an account and sign in.
How does Insight help with literature reviews?
Insight lets you define a research objective and run PubMed tasks that search peer-reviewed biomedical literature. It produces scientific summaries with citations, helping researchers review large article sets without manually reading every source.
What is Insight Discovery?
Insight Discovery is a high-throughput module for identifying new therapeutic targets, subpopulations, and biomarkers through multivariate integration. It is separate from Insight Research and currently requires joining a waitlist.
How can I contact the Insight team?
You can email [email protected] or [email protected], join the Discord community, or reach the team on LinkedIn and X (Twitter). The contact page lists [email protected] as the primary email.

